Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

October 01, 2020; Volume 98,Issue 4

Special Section on 50 Years of Opioid Research

  • You have access
    Editorial: 50 Years of Opioid Research and the International Narcotics Research Conference
    Manojkumar A. Puthenveedu
    Molecular Pharmacology October 2020, 98 (4) 386-388; DOI: https://doi.org/10.1124/molpharm.120.000132
  • You have access
    Opioid Research: Past and Future
    Rita J. Valentino and Nora D. Volkow
    Molecular Pharmacology October 2020, 98 (4) 389-391; DOI: https://doi.org/10.1124/molpharm.120.000093
  • You have access
    A Concise Review of Concepts in Opioid Pharmacology up to the Discovery of Endogenous Opioids
    Brian M. Cox
    Molecular Pharmacology October 2020, 98 (4) 392-400; DOI: https://doi.org/10.1124/mol.120.119420
  • Open Access
    Recent Progress in Opioid Research from an Electrophysiological Perspective
    William T. Birdsong and John T. Williams
    Molecular Pharmacology October 2020, 98 (4) 401-409; DOI: https://doi.org/10.1124/mol.119.119040
  • You have access
    Intrinsic Efficacy of Opioid Ligands and Its Importance for Apparent Bias, Operational Analysis, and Therapeutic Window
    Alexander Gillis, Varun Sreenivasan and Macdonald J. Christie
    Molecular Pharmacology October 2020, 98 (4) 410-424; DOI: https://doi.org/10.1124/mol.119.119214
  • You have access
    Opioid Pharmacology under the Microscope
    Damien Jullié, Arisbel B. Gondin, Mark von Zastrow and Meritxell Canals
    Molecular Pharmacology October 2020, 98 (4) 425-432; DOI: https://doi.org/10.1124/mol.119.119321
  • You have access
    Pain, Motivation, Migraine, and the Microbiome: New Frontiers for Opioid Systems and Disease
    Kyle E. Parker, Elizabeth Sugiarto, Anna M.W. Taylor, Amynah A. Pradhan and Ream Al-Hasani
    Molecular Pharmacology October 2020, 98 (4) 433-444; DOI: https://doi.org/10.1124/mol.120.119438
  • Open Access
    Bidirectional Relationship between Opioids and Disrupted Sleep: Putative Mechanisms
    D. Eacret, S.C. Veasey and J.A. Blendy
    Molecular Pharmacology October 2020, 98 (4) 445-453; DOI: https://doi.org/10.1124/mol.119.119107
  • You have access
    Neprilysin Controls the Synaptic Activity of Neuropeptides in the Intercalated Cells of the Amygdala
    G.C. Gregoriou, S.D. Patel, B.L. Winters and E.E. Bagley
    Molecular Pharmacology October 2020, 98 (4) 454-461; DOI: https://doi.org/10.1124/mol.119.119370
  • You have access
    Unique Pharmacological Properties of the Kappa Opioid Receptor Signaling Through Gαz as Shown with Bioluminescence Resonance Energy Transfer
    Miriam E. Barnett, Brian I. Knapp and Jean M. Bidlack
    Molecular Pharmacology October 2020, 98 (4) 462-474; DOI: https://doi.org/10.1124/mol.120.119404
  • Open Access
    Atomic-Level Characterization of the Methadone-Stabilized Active Conformation of µ-Opioid Receptor
    Abhijeet Kapoor, Davide Provasi and Marta Filizola
    Molecular Pharmacology October 2020, 98 (4) 475-486; DOI: https://doi.org/10.1124/mol.119.119339
  • You have access
    Spinal Opioid Tolerance Depends upon Platelet-Derived Growth Factor Receptor-β Signaling, Not μ-Opioid Receptor Internalization
    S. Puig, K.E. Barker, S.R. Szott, P.T. Kann, J.S. Morris and H.B. Gutstein
    Molecular Pharmacology October 2020, 98 (4) 487-496; DOI: https://doi.org/10.1124/mol.120.119552
  • You have access
    Chronic Treatment with Morphine Disrupts Acute Kinase-Dependent Desensitization of GPCRs
    Emily R. Leff, Seksiri Arttamangkul and John T. Williams
    Molecular Pharmacology October 2020, 98 (4) 497-507; DOI: https://doi.org/10.1124/mol.119.119362
  • You have access
    Fentanyl-Induced Block of hERG Channels Is Exacerbated by Hypoxia, Hypokalemia, Alkalosis, and the Presence of hERG1b
    Jared N. Tschirhart and Shetuan Zhang
    Molecular Pharmacology October 2020, 98 (4) 508-517; DOI: https://doi.org/10.1124/mol.119.119271
  • You have access
    A Truncated Six Transmembrane Splice Variant MOR-1G Enhances Expression of the Full-Length Seven Transmembrane μ-Opioid Receptor through Heterodimerization
    Tiffany Zhang, Jin Xu and Ying-Xian Pan
    Molecular Pharmacology October 2020, 98 (4) 518-527; DOI: https://doi.org/10.1124/mol.120.119453

Editorial

  • You have access
    “Emerging Concepts”: New Article Category in Molecular Pharmacology
    David A. Gewirtz
    Molecular Pharmacology October 2020, 98 (4) 350; DOI: https://doi.org/10.1124/molpharm.120.000133

Emerging Concepts

  • You have access
    Weak Microbial Metabolites: a Treasure Trove for Using Biomimicry to Discover and Optimize Drugs
    Zdenek Dvorak, Max Klapholz, Thomas P. Burris, Benjamin P. Willing, Antimo Gioiello, Roberto Pellicciari, Francesco Galli, John March, Stephen J. O’Keefe, R. Balfour Sartor, Chang H. Kim, Maayan Levy and Sridhar Mani
    Molecular Pharmacology October 2020, 98 (4) 343-349; DOI: https://doi.org/10.1124/molpharm.120.000035

Minireview

  • You have access
    Targeting Vesicular Glutamate Transporter Machinery: Implications on Metabotropic Glutamate Receptor 5 Signaling and Behavior
    Karim S. Ibrahim, Khaled S. Abd-Elrahman, Salah El Mestikawy and Stephen S.G. Ferguson
    Molecular Pharmacology October 2020, 98 (4) 314-327; DOI: https://doi.org/10.1124/molpharm.120.000089

Articles

  • You have access
    Analysis of Modulation of the ρ1 GABAA Receptor by Combinations of Inhibitory and Potentiating Neurosteroids Reveals Shared and Distinct Binding Sites
    Allison L. Germann, David E. Reichert, Ariel B. Burbridge, Spencer R. Pierce, Alex S. Evers, Joe Henry Steinbach and Gustav Akk
    Molecular Pharmacology October 2020, 98 (4) 280-291; DOI: https://doi.org/10.1124/mol.120.119842
  • You have access
    Differing Activity Profiles of the Stereoisomers of 2,3,5,6TMP-TQS, a Putative Silent Allosteric Modulator of α7 nAChR
    Roger L. Papke, Sumanta Garai, Clare Stokes, Nicole A. Horenstein, Arthur D. Zimmerman, Khalil A. Abboud and Ganesh A. Thakur
    Molecular Pharmacology October 2020, 98 (4) 292-302; DOI: https://doi.org/10.1124/mol.120.119958
  • You have access
    Enhancement of Muscimol Binding and Gating by Allosteric Modulators of the GABAA Receptor: Relating Occupancy to State Functions
    Gustav Akk, Allison L. Germann, Yusuke Sugasawa, Spencer R. Pierce, Alex S. Evers and Joe Henry Steinbach
    Molecular Pharmacology October 2020, 98 (4) 303-313; DOI: https://doi.org/10.1124/molpharm.120.000066
  • You have access
    Nicotinic Acetylcholine Receptor Accessory Subunits Determine the Activity Profile of Epibatidine Derivatives
    Lu Wenchi Corrie, Clare Stokes, Jenny L. Wilkerson, F. Ivy Carroll, Lance R. McMahon and Roger L. Papke
    Molecular Pharmacology October 2020, 98 (4) 328-342; DOI: https://doi.org/10.1124/molpharm.120.000037
  • You have access
    Dietary Caffeine Synergizes Adverse Peripheral and Central Responses to Anesthesia in Malignant Hyperthermia Susceptible Mice
    Monica Aleman, Rui Zhang, Wei Feng, Lihong Qi, Jose R. Lopez, Chelsea Crowe, Yao Dong, Genady Cherednichenko and Isaac N. Pessah
    Molecular Pharmacology October 2020, 98 (4) 351-363; DOI: https://doi.org/10.1124/mol.120.119412
  • Open Access
    Pharmacology and Molecular Mechanisms of Clinically Relevant Estrogen Estetrol and Estrogen Mimic BMI-135 for the Treatment of Endocrine-Resistant Breast Cancer
    Balkees Abderrahman, Philipp Y. Maximov, Ramona F. Curpan, Jay S. Hanspal, Ping Fan, Rui Xiong, Debra A. Tonetti, Gregory R.J. Thatcher and V. Craig Jordan
    Molecular Pharmacology October 2020, 98 (4) 364-381; DOI: https://doi.org/10.1124/molpharm.120.000054

Letter to the editor

  • You have access
    Commentary on: “Does COVID19 Infect the Brain? If So, Smokers Might Be at a Higher Risk”
    Robert C. Speth
    Molecular Pharmacology October 2020, 98 (4) 382-383; DOI: https://doi.org/10.1124/molpharm.120.000049

Response to Letter to the Editor

  • You have access
    Response to Comments on “Does COVID19 Infect the Brain? If So, Smokers Might Be at a Higher Risk”
    N. Kabbani and J.L. Olds
    Molecular Pharmacology October 2020, 98 (4) 384-385; DOI: https://doi.org/10.1124/molpharm.120.000120

Erratum

  • You have access
    Correction to “Pharmacology and Molecular Mechanisms of Clinically Relevant Estrogen Estetrol and Estrogen Mimic BMI-135 for the Treatment of Endocrine-Resistant Breast Cancer”
    Molecular Pharmacology October 2020, 98 (4) 528; DOI: https://doi.org/10.1124/molpharm.120.000054err
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 98 (4)
Molecular Pharmacology
Vol. 98, Issue 4
1 Oct 2020
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Special Section on 50 Years of Opioid Research
  • Editorial
  • Emerging Concepts
  • Minireview
  • Articles
  • Letter to the editor
  • Response to Letter to the Editor
  • Erratum
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics